Literature DB >> 2790622

Epidemiologic features of hepatitis B virus infection in northern Labrador.

M Baikie1, S Ratnam, D G Bryant, M Jong, M Bokhout.   

Abstract

We studied the epidemiologic features of hepatitis B virus (HBV) infection in northern Labrador to determine the prevalence of the infection and to obtain a database to develop a vaccination strategy. The study population included seven communities in which five ethnic groups were represented: Inuit, Innu, mixed Inuit and European ancestry ("settler"), nonnative/nonsettler transient population ("white") and people of Innu-white or Innu-Inuit origin ("mixed"). Blood samples from 2156 people (62% of the area residents) were tested for antibody to HBV core antigen (anti-HBc), HBV surface antigen (HBsAg), HBV e antigen (HBeAg), anti-HBc IgM and antibody to the surface antigen (anti-HBs). The overall crude prevalence rate of HBV seromarkers was 14.7% and the HBsAg carrier rate at least 3.2%; the rates were highest for Inuit (26.4% and 6.9% respectively), followed by settler (10.0% and 1.9% respectively) and Innu (7.6% and 0.4% respectively); the white and mixed groups had the lowest overall rates (2.5% and 3.3% respectively). Although the overall prevalence rates were about the same for the two sexes, the HBsAg carrier rate was higher in males (male:female ratio 1.6:1.0). No HBV carriers were positive for HBeAg or anti-HBc IgM antibody. The rate of exposure to HBV was 4% for those below the age of 20 years and reached a peak for those aged 45 to 54 years (85% for Inuit, 40% for settlers and 37% for Innu). There was also a wide variation in the age-standardized prevalence rates (0% to 27.9%) among the ethnic groups in the seven communities surveyed.

Entities:  

Mesh:

Year:  1989        PMID: 2790622      PMCID: PMC1451300     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  8 in total

1.  Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome.

Authors:  A I Sutnick; W T London; B J Gerstley; M M Cronlund; B S Blumberg
Journal:  JAMA       Date:  1968-09-02       Impact factor: 56.272

2.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis.

Authors:  B S Blumberg; B J Gerstley; D A Hungerford; W T London; A I Sutnick
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

3.  Natural history of hepatitis-associated antigen-positive chronic liver disease.

Authors:  F J Dudley; P J Scheuer; S Sherlock
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

4.  Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population.

Authors:  G Y Minuk; L E Nicolle; B Postl; J G Waggoner; J H Hoofnagle
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

5.  Epidemiology of hepatitis B in two Alaska communities.

Authors:  D H Barrett; J M Burks; B McMahon; S Elliott; K R Berquist; T R Bender; J E Maynard
Journal:  Am J Epidemiol       Date:  1977-02       Impact factor: 4.897

6.  Hepatitis and hepatitis B-antigen in Greenland. II: Occurrence and interrelation of hepatitis B associated surface, core, and "e" antigen-antibody systems in a highly endemic area.

Authors:  P Skinhoj
Journal:  Am J Epidemiol       Date:  1977-02       Impact factor: 4.897

7.  Prevalence of hepatitis B in selected Alaskan Eskimo villages.

Authors:  M T Schreeder; T R Bender; B J McMahon; M R Moser; B L Murphy; M J Sheller; W L Heyward; D B Hall; J E Maynard
Journal:  Am J Epidemiol       Date:  1983-10       Impact factor: 4.897

8.  The control of hepatitis B virus infection with vaccine in Yupik Eskimos. Demonstration of safety, immunogenicity, and efficacy under field conditions.

Authors:  W L Heyward; T R Bender; B J McMahon; D B Hall; D P Francis; A P Lanier; W L Alward; J L Ahtone; B L Murphy; J E Maynard
Journal:  Am J Epidemiol       Date:  1985-06       Impact factor: 4.897

  8 in total
  4 in total

1.  Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992-2003.

Authors:  Z Hong; G Smart; G Zaniewski; H Wu; J Wu; N Goedhuis; A Giulivi; K Kaita; M Dawood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

Review 2.  Hepatitis B among Inuit: A review with focus on Greenland Inuit.

Authors:  Karsten Fleischer Rex; Stig Andersen; Henrik Bygum Krarup
Journal:  World J Hepatol       Date:  2015-05-28

3.  Chronic hepatitis B infection in Canada.

Authors:  G Y Minuk; J Uhanova
Journal:  Can J Infect Dis       Date:  2001-11

4.  Epidemiology of hepatitis B in Canada.

Authors:  J Zhang; S Zou; A Giulivi
Journal:  Can J Infect Dis       Date:  2001-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.